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Background: Limited clinical data are available about the association between inflammation and the risk of developing hypertension. The purpose 
of this study was to determine the association of serum high sensitive C-reactive protein (hs-CRP), a marker of systemic inflammation, with the risk of 
developing hypertension in nonhypertensive individuals. 
Methods: Study subjects were 710 Koreans (263 males; mean age = 54.5±9.1 year-old) in a rural area in Daegu city, Korea. They were enrolled 
from August to November 2003 for a cohort study. Of these patients, 452 (63.7%) nonhypertensive individuals were finally analyzed in this study. 
Baseline levels of serum hs-CRP were measured by immunoturbidimetric assay. Primary endpoint was incident cases of hypertension, defined as 
either a new physician diagnosis or self-reports of newly initiated antihypertensive treatment. 
Results: Baseline hs-CRP levels were significantly higher in prehypertensive individuals compared to normotensive individuals (1.26±1.60 mg/L 
versus 0.94±1.32 mg/L, p=0.026). During the 5-year follow-up, 99 (21.9%) of 452 non-hypertensive individuals developed incident hypertension. 
The hs-CRP levels were significantly higher in patients with incident hypertension (1.05±1.40 mg/L versus 1.41±1.62 mg/L, p=0.027). In 
multivariate analysis log transformed hs-CRP (Odds ratio [OR] 2.038, 95% confidence interval [CI] 1.128-3.683; p=0.018) in addition to systolic 
blood pressure (OR 1.070, 95% CI 1.029-1.112; p=0.001) were independent predictors of developing hypertension after adjusting for confounding 
variables. The combination of systolic blood pressure and hs-CRP levels showed incremental prognostic value to predict incident hypertension. In 
fully adjusted models, the ORs (95% CI) of developing hypertension from lowest (referent) to the highest levels of hs-CRP were 1.0, 1.84 (0.94-3.59), 
2.45 (1.26-4.76). 
Conclusions: This study provides evidence that baseline levels of hs-CRP are modestly associated with an increased risk of developing 
hypertension. These data suggest that inflammation may have a potentially important role in part in the development of hypertension.
